α-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-07-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.104.507699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing

  2004cited by this paper
• Changes in myocardial gene expression associated with β-blocker therapy in patients with chronic heart failure

  2003cited by this paper
• Visualization of an unstable coiled coil from the scallop myosin rod

  2003cited by this paper
• Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy

  2003cited by this paper
• Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment

  2003cited by this paper
• Mutations of the Light Meromyosin Domain of the &bgr;-Myosin Heavy Chain Rod in Hypertrophic Cardiomyopathy

  2002cited by this paper
• Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly

  2002cited by this paper
• Small Amounts of &agr;-Myosin Heavy Chain Isoform Expression Significantly Increase Power Output of Rat Cardiac Myocyte Fragments

  2002cited by this paper
• Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.

  2002cited by this paper
• Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.

  2001cited by this paper
• Myosin heavy chain isoform expression in the failing and nonfailing human heart.

  2000cited by this paper
• NPS@: network protein sequence analysis.

  2000cited by this paper
• Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

  1999cited by this paper
• Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.

  1999cited by this paper
• A conserved C-terminal assembly region in paramyosin and myosin rods.

  1998cited by this paper
• A 29 residue region of the sarcomeric myosin rod is necessary for filament formation.

  1997cited by this paper
• Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

  1997cited by this paper
• Myosin heavy chain gene expression in human heart failure.

  1997cited by this paper
• The mammalian myosin heavy chain gene family.

  1996cited by this paper
• A Mouse Model of Familial Hypertrophic Cardiomyopathy

  1996cited by this paper
• Familial dilated cardiomyopathy

  1993cited by this paper
• Three-dimensional structure of myosin subfragment-1: a molecular motor.

  1993cited by this paper
• Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.

  1992cited by this paper
• Improvements in protein secondary structure prediction by an enhanced neural network.

  1990cited by this paper
• Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles.

  1986cited by this paper
• Familial dilated cardiomyopathy.

  1984cited by this paper
• Periodic features in the amino acid sequence of nematode myosin rod.

  1983cited by this paper
• Molecular Pathology

  1976cited by this paper

• Fabry disease cardiomyopathy: A state-of-the-art review.

  2025cites this paper
• A gene regulatory element modulates myosin expression and controls cardiomyocyte response to stress

  2025cites this paper
• Identification of biomarkers and immune microenvironment associated with heart failure through bioinformatics and machine learning

  2025cites this paper
• HSPA2 as a potential lactylation-related key gene in heart failure identified by integrated bioinformatics analysis

  2025cites this paper
• JCS/JCC/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease.

  2025cites this paper
• A phenotypic screen identified KEAP1-kelch domain blockade as a mechanism to restore cardiac function in the setting of chronic severe hemodynamic stress

  2025cites this paper
• Clinical and Genetic Heterogeneity of HCM: The Possible Role of a Deletion Involving MYH6 and MYH7

  2025cites this paper
• A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy

  2025cites this paper
• Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients

  2025cites this paper
• Novel nonsense mutation in MYH6 gene identified as the cause of familial hypertrophic cardiomyopathy – A case report and literature review

  2025cites this paper
• Exosomal lncRNA Profiles in Patients with HFrEF : Evidence for KLF3-AS1 as a Novel Diagnostic Biomarker.

  2025cites this paper
• A gene regulatory element modulates myosin expression and controls cardiomyocyte response to stress

  2025cites this paper
• Identification of rare disease genes as drivers of common diseases through tissue-specific gene regulatory networks

  2024cites this paper
• Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review

  2024cites this paper
• The nutrient sensor CRTC and Sarcalumenin/thinman represent an alternate pathway in cardiac hypertrophy

  2024cites this paper
• Generation of a human induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient carrying MYH6/c.611G>A mutation.

  2024cites this paper
• Current Concepts in the Epigenetic Regulation of Cardiac Fibrosis.

  2024cites this paper
• Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis

  2024cites this paper
• Effects of a Global Rab27a Null Mutation on Murine PVAT and Cardiovascular Function

  2024cites this paper
• Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy

  2023cites this paper
• Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments

  2023cites this paper
• Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit

  2023cites this paper
• Tumor Necrosis Factor-α Mediates Inflammation-induced Early-Stage Left Ventricular Systolic Dysfunction

  2023cites this paper
• Adaptive sampling for nanopore direct RNA-sequencing

  2023cites this paper
• Left ventricular hypertrophy and metabolic resetting in the Notch3-deficient adult mouse heart

  2023cites this paper
• Genomic and transcriptomic characterization of pre-operative chemotherapy response in patients with osteosarcoma

  2023cites this paper
• Changes of ubiquitylated proteins in atrial fibrillation associated with heart valve disease: proteomics in human left atrial appendage tissue

  2023cites this paper
• Single-nucleus RNA sequencing in ischemic cardiomyopathy reveals common transcriptional profile underlying end-stage heart failure

  2023cites this paper
• Sudden Cardiac Death in Biventricular Arrhythmogenic Cardiomyopathy: A New Undescribed Variant of the MYH6 Gene

  2023cites this paper
• Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure

  2022cites this paper
• Determining the Likelihood of Disease Pathogenicity Among Incidentally Identified Genetic Variants in Rare Dilated Cardiomyopathy‐Associated Genes

  2022cites this paper
• Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects

  2022cites this paper
• Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases

  2022cites this paper
• Genome-wide association analysis reveals insights into the genetic architecture of right ventricular structure and function

  2022cites this paper
• Adaptive Sampling as tool for Nanopore direct RNA-sequencing

  2022cites this paper
• Model Embraced Electromechanical Coupling Time for Estimation of Heart Failure in Patients With Hypertrophic Cardiomyopathy

  2022cites this paper
• Deep learning on resting electrocardiogram to identify impaired heart rate recovery

  2022cites this paper
• Leveraging Spaceflight to Advance Cardiovascular Research on Earth

  2022cites this paper
• A double heterozygous variant in MYH6 and MYH7 associated with hypertrophic cardiomyopathy in a Japanese Family.

  2021cites this paper
• Linking common and rare disease genetics through gene regulatory networks

  2021cites this paper
• Deregulation of Extracellular Matrix Components in Hypertrophic and Dilated Cardiomyopathy

  2021cites this paper
• Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review

  2021cites this paper
• Vitamin E deficiency ataxia in a family with possible cardiac involvement

  2021cites this paper
• Genetics of congenital heart disease: a narrative review of recent advances and clinical implications

  2021cites this paper
• Identification of MYH6 as the potential gene for human ischaemic cardiomyopathy

  2021cites this paper
• Genetic contributions to the expression of acquired causes of cardiac hypertrophy in non-ischemic sudden cardiac death victims

  2021cites this paper
• Novel insertion mutation (Arg1822_Glu1823dup) in MYH6 coiled-coil domain causing familial atrial septal defect.

  2021cites this paper
• Generation and characterization of a Myh6-driven Cre knockin mouse line

  2021cites this paper
• Young and early‐onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations

  2021cites this paper
• Genome-Wide Identification, Characterization and Expression Profiling of myosin Family Genes in Sebastes schlegelii

  2021cites this paper
• A Case Report of Genetic Cascade Screening in Dilated Cardiomyopathy: A Perspective for Preventive Cardiology

  2021cites this paper
• Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes

  2021cites this paper
• Alpha and beta myosin isoforms and human atrial and ventricular contraction

  2021cites this paper
• Motor Proteins and Spermatogenesis.

  2021cites this paper
• Molecular Genetic Basis of Hypertrophic Cardiomyopathy.

  2021cites this paper
• Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation

  2021cites this paper
• Application of CRISPR-Cas9 gene editing for congenital heart disease

  2021cites this paper
• Identification of Upstream Transcriptional Regulators of Ischemic Cardiomyopathy Using Cardiac RNA-Seq Meta-Analysis

  2020cites this paper
• Myosins and Disease.

  2020cites this paper
• DHA Supplementation Attenuates MI-Induced LV Matrix Remodeling and Dysfunction in Mice

  2020cites this paper
• Heart Failure as a Consequence of Hypertrophic Cardiomyopathy

  2020cites this paper
• Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq

  2020cites this paper
• Redox à la carte: Novel chemogenetic models of heart failure

  2020cites this paper
• Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets

  2020cites this paper
• Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy.

  2020cites this paper
• The Genetic Puzzle of Familial Atrial Fibrillation

  2020cites this paper
• Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene.

  2020cites this paper
• Establishment of a human MYH6 compound heterozygous knockout hESC line to model cardiomyopathy and congenital heart defects by CRISPR/Cas9 system.

  2020cites this paper
• Progressive Proteome Changes in the Myocardium of a Pig Model for Duchenne Muscular Dystrophy

  2020cites this paper
• Genetic Association between Hypoplastic Left Heart Syndrome and Cardiomyopathies.

  2020cites this paper
• Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation

  2020cites this paper
• Identification of known and unknown genes associated with mitral valve prolapse using an exome slice methodology

  2020cites this paper
• SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy

  2020cites this paper
• Cell type-specific weighting-factors to solve solid organs-specific limitations of single cell RNA-sequencing

  2020cites this paper
• Identification of candidate genes in ischemic cardiomyopathy by gene expression omnibus database

  2020cites this paper
• Disease mutations in striated muscle myosins

  2020cites this paper
• Vitamin E deficiency ataxia in a family with possible cardiac involvement.

  2020cites this paper
• Nanoplastics impact the zebrafish (Danio rerio) transcriptome: Associated developmental and neurobehavioral consequences.

  2020cites this paper
• Using Zebrafish to Analyze the Genetic and Environmental Etiologies of Congenital Heart Defects.

  2020cites this paper
• Dilated Cardiomyopathy

  2020cites this paper
• Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies

  2019cites this paper
• A Human Embryonic Stem Cell Reporter Line for Monitoring Chemical-induced Cardiotoxicity.

  2019cites this paper
• Targeted molecular genetic testing in young sudden cardiac death victims from Western Denmark

  2019cites this paper
• In utero exposure to diesel exhaust is associated with alterations in neonatal cardiomyocyte transcription, DNA methylation and metabolic perturbation

  2019cites this paper
• Green tea extract catechin improves cardiac function in pediatric cardiomyopathy patients with diastolic dysfunction

  2019cites this paper
• Avian Cardiovascular Disease Characteristics, Causes and Genomics

  2018cites this paper
• Proteomic Approach to Discover Potential Biomarkers for Heart Failure

  2018cites this paper
• Genome-wide studies of heart failure and endophenotypes: lessons learned and future directions

  2018cites this paper
• Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies

  2018cites this paper
• Whole-exome sequencing identifies R1279X of MYH6 gene to be associated with congenital heart disease

  2018cites this paper
• Hypertrophic Cardiomyopathy in the Era of Genomic Medicine

  2018cites this paper
• A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta

  2018cites this paper
• Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology

  2018cites this paper
• Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J‐Leprdb mice

  2018cites this paper
• Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.

  2018cites this paper
• Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice

  2018cites this paper
• Progress of Genetics in Inherited Cardiomyopathies-Induced Heart Failure

  2018cites this paper
• Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy

  2017cites this paper
• Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics

  2017cites this paper
• How do regulated thin filaments with hypertrophic cardiomyopathy-linked α-cardiac actin affect actomyosin interactions?

  2017cites this paper